Pricing and reimbursement of pharmaceuticals in Portugal

被引：0

作者：

Pinto C.G. ^{[1
,2
]}

Teixeira I.

机构：

[1] Inst. of Econ./Bus. Administration, Technical University of Lisbon, Lisbon

[2] 1200-725 Lisbon

来源：

The European Journal of Health Economics | 2002年 / 3卷 / 4期

关键词：

Pharmaceutical policy; Portugal;

D O I：

10.1007/s10198-002-0146-1

中图分类号：

学科分类号：

摘要：

The pricing and reimbursement systems in Portugal are quite complex. This is due not only to the general characteristics of the Portuguese NHS but also to the past evolution of these systems. In this article we explain the main features of pharmaceutical policy in Portugal regarding pricing and reimbursement of medicines. Causes of government concern with expenditure and policies aiming at controlling it are pointed out. Policies are described through presentation of the most recent legislation approved on the issues analysed.

引用

页码：267 / 270

页数：3

共 6 条

[1]

Estatística do Medicamento - 2000, (2000)

[2]

Miranda M.A., A comparticipação do Estado nos medicamentos: Evolução do sistema, 1as Jornadas do INFARMED. Medicamento: As Políticas Nacionais Face ȧ Internacionalização, pp. 59-73, (1997)

[3]

The Reform of Health Care Systems: A Review of 17 OECD Countries, (1994)

[4]

OECD Health Data 2002, (2002)

[5]

Pinto C.G., Oliveira M., The Portuguese health care system: Current organisation and perspectives for reform, Como Está a Economia Portuguesa?, pp. 161-193, (2001)

[6]

Silva E.A., Pinto C.G., Sampaio C., Pereira J.A., Drummond M., Trindade R., Orientações Metodológicas para Estudos de Avaliação Económica de Medicamentos, (1998)

← 1 →